A case report of anaesthesia for a patient with dystrophia myotonica undergoing insertion of an endocardial permanent pacemaker is presented. The value of Althesin as the major anaesthetic agent in these patients is outlined, especially with respect to its cardiovascular stability and rapid recovery.
Dystrophia myotonica is a hereditary disease characterised by myotonia, muscular wasting, cataracts, gonadal atrophy and frontal baldness. Mental retardation and dystrophic heart disease are common findings in these patients. Since it is a rare disease there are only a few reports of anaesthesia for such patients. No previously published report has dealt with the insertion of a permanent pacemaker in a patient with this disease.
CASE REPORT A 19-year-old girl weighing 37 kg presented with a five month history of frequent syncope. The frequency of these episodes varied from seven times a day to weeks apart. She also gave a history of palpitations, both rapid and slow, not related to the syncopal attacks.
On examination she had subnormal intelligence, myopathic facies, ptosis, dysarthria, myotonia of the hands, mild distal weakness of the lower limbs, absent ankle jerks, frontal baldness and cardiac arrhythmias. There was a strong family history of the disease. An ECG showed atrioventricular junctional re-entry tachycardia, prolonged His bundle-ventricular interval (64 milliseconds; normal: 52 milliseconds), and rapid anterograde and retrograde conduction through the atrioventricular node (atrioventricular Wenckebach: l80/min; ventriculoatrial Wenckebach: l60/min). It was considered that a permanent endocardial pacemaker was indicated to prevent further syncopal attacks.
Preoperatively, there were no clinical signs of a cardiomyopathy and the electrocardiogram showed multiple unifocal ventricular ectopic beats. Her haemoglobin, blood biochemistry and chest X-ray were normal.
The patient fasted for eight hours preoperatively. Premedicant drugs were omitted. Preinduction systolic blood pressure was 105 mmHg, pulse rate 88 beats per minute (sinus rhythm), and respiratory rate 18 per minute. The ECG, blood pressure, pulse rate and respiratory rate were then monitored regularly throughout the procedure. Following positioning on the operating table and preoxygenation for three minutes, atropine 400 micrograms and fentanyl 25 micrograms were given intravenously. Induction was achieved with an infusion of a 1: 10 dilution of Althesin in a dextrose/saline solution (1.2 mg total steroid per millilitre concentration). After 25 ml of the solution (i.e. 30 mg total steroid), given over two minutes, the patient was asleep. Anaesthesia was maintained by continuing the infusion at approximately one third the induction rate (i.e. 5 mg total steroid per minute). It was supplemented with 506,10 N 2 0 in 02 with the patient breathing spontaneously through a semi-closed circle system with sodalime.
The skin incision caused mild myotonia in the right arm but this was controlled with another increment of 25 micrograms of fentanyl and a slight increase in the Althesin infusion rate. Immediately respiration became shallow and slowed to ten breaths per minute, requiring assisted ventilation for a brief period. At no time was there any difficulty with assisted ventilation. Spontaneous respiration soon settled at 16 breaths per minute. The ECG showed an occasional ventricular ectopic beat. Her pulse rate and blood pressure remained within normal limits throughout.
Towards the end of the surgical procedure, thirty minutes after induction, the infusion was stopped and the nitrous oxide turned off. The patient woke up after ten minutes. The total dose of Althesin was 120 mg. On emergence a mild degree of myotonia was detected in the left arm. This resolved without treatment. Her respiratory rate rose to 16 per minute. She was able to respond to verbal commands. She was then escorted to the recovery room breathing oxygen enriched air. Her further progress was uneventful.
DISCUSSION
Patients with dystrophia myotonica face numerous major hazards in the perioperative period. These include: 1. increased susceptibility to central nervous system depressants; 2. unpredictable response to muscle relaxants, especially the depolarising type; 3. impaired pulmonary mechanics, secondary to atrophic respiratory musculature; 4. cardiovascular instability from dystrophic heart disease; 5. severe myotonic contractions of skeletal muscle which may prevent adequate airway Halothane may be contraindicated because of a varying degree of cardiac involvement. 5 Furthermore, it may predispose to postoperative shivering which may induce myotonia. 4 Using suxamethonium Mitchell et al. 6 elicited myotonic contractions proportional to the dose given. Drugs that facilitate depolarisation of the neuromuscular junction such as neostigmine are reported 6 to increase the myotonic response in man. This effect of neostigmine may be relatively benign. However, it places doubt upon the use of nondepolarising muscle relaxants.
Wheeler and J ames 7 advocated the use of local or regional anaesthesia in these patients. This technique does not, however, prevent myotonic responses to surgical stimulation. Moreover regional or local anaesthesia may not be suitable in the high percentage of mentally retarded patients with this condition. Suppan 8 and Muller and Suppan 9 have found Althesin infusions and pancuronium a satisfactory anaesthetic combination in dystrophia myotonica. They postulated a peripheral effect of Althesin on (or in) the muscle fibre itself, providing muscle relaxation and abolishing myotonia. One case 9 required postoperative ventilation, possibly because of the unpredictable response to pancuronium. The rapid induction and smooth maintenance of anaesthesia with infusions of Althesin are associated with minimal cardiovascular disturbance. This is consistent with the high therapeutic index and inherent cardiovascular stability associated with this drug and technique. IO ,!! The slow infusion technique allows for adjustments according to the individual response. Small doses of fentanyl were given without respiratory depression arising in the postoperative period. The respiratory depressant effects of Althesin are dose-dependent. 10 In this patient respiratory depression was not a problem when it was administered at the maintenance rate.
It is concluded that the use of central nervous system depressants that are either short acting and non-cumulative or easily reversed can be used to anaesthetise these high risk patients. Muscle relaxants should be avoided if possible.
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